Wave Life Sciences WVE Cash Flow Statement (2014-2026)

NASDAQ WVE
$4.84 +0.14 (+2.87%)
As of: Sep 4, 2026 · 2:23 PM EDT
Reported Financials

Wave Life Sciences Quarterly Cash Flow Statement

Periods 48 quarters
Latest Jun 2026

Wave Life Sciences reported cash from operations of -$53.58M and free cash flow of -$54.47M for the quarter ended Jun 2026, down 16.5% year over year. This cash flow statement covers 48 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-6.23M-34.78M-37.81M-41.30M-39.00M-43.71M-27.41M-21.10M7.28M-16.28M-31.56M-32.92M-61.78M29.25M-46.88M-50.47M-53.85M-53.18M-26.09M-69.36M
Share-based CompensationStock Comp.
5.90M3.73M3.97M8.04M2.28M2.91M2.75M2.41M2.28M2.35M2.88M3.48M3.53M3.24M4.95M6.20M6.47M7.35M9.06M20.95M
Deferred Taxes
Cash from OperationsCash from Ops.
-28.18M-7.03M-39.87M-28.82M-25.65M-33.44M85.52M-37.26M-34.46M-33.24M-33.43M-27.47M-46.48M-43.65M-63.04M-46.01M-44.67M-33.78M-59.55M-53.58M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.55M0.76M0.78M0.81M0.96M0.98M1.00M1.03M1.07M1.10M1.14M1.17M1.21M1.25M1.29M1.33M1.37M1.42M1.46M1.51M
Amortization of Deferred ChargesAmort. Deferred Charges
0.55M0.76M0.78M0.81M0.96M0.98M1.00M1.03M1.07M1.10M1.14M1.17M1.21M1.25M1.29M1.33M1.37M1.42M1.46M1.51M
Depreciation & Amortization (CF)Dep. & Amort.
Change in Working Capital
Change in ReceivablesChange Receivables
-37.50M-22.50M7.00M14.09M-21.09M1.29M-1.29M1.42M-1.42M1.62M8.38M-8.72M-1.28M0.89M
Change in Account PayablesChange Payables
-1.08M-0.23M2.49M0.77M5.07M1.01M-4.67M0.22M0.50M0.19M-1.07M6.11M-5.08M3.46M-2.05M0.28M0.06M1.16M3.29M1.57M
Change in Accured ExpensesChange Accured Exp.
1.44M3.50M-7.93M4.16M-0.03M6.50M-9.93M2.81M2.19M4.20M-10.21M4.06M3.46M6.94M-13.27M5.21M3.46M10.08M-13.52M5.20M
Other Working Capital ChangesOther WC Changes
-13.92M-1.76M-1.58M-0.27M-0.15M-1.24M126.45M-22.11M-42.04M-7.97M-12.54M-6.40M7.68M-82.33M-9.18M-7.08M2.39M-5.97M-28.25M-1.39M
Investing Activities
Capital ExpendituresCapex
0.10M0.01M0.21M0.49M0.46M0.20M0.49M0.07M0.20M0.36M0.42M0.05M0.38M0.09M0.17M0.31M0.25M-0.00M0.44M0.88M
Change in Acquisitions & DivestmentsChange Acquisitions
25.00M25.04M
Cash from Investing ActivitiesCash from Investing
-0.10M-0.01M-50.21M24.61M-0.50M24.84M-0.49M-0.07M-0.20M-0.36M-0.42M-0.05M-0.38M-0.09M-0.17M-0.31M-0.25M0.00M-0.44M-123.45M
Financing Activities
Other financing activitiesOther financing
0.27M0.17M14.16M-0.06M-13.90M0.43M0.32M0.35M13.75M-11.12M2.45M0.59M2.04M9.78M1.93M0.33M
Cash from Financing ActivitiesCash from Financing
8.35M33.79M1.32M65.80M0.02M0.06M35.05M1.85M1.67M93.96M14.51M0.65M203.75M34.98M4.16M11.69M32.69M439.69M2.53M0.33M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
8.03M33.79M1.10M50.36M-0.23M-0.01M93.57M14.04M173.90M13.82M330.91M
Additional items
Exchange Rate EffectFX Effect
-0.01M-0.08M-0.09M-0.14M-0.08M0.09M-0.02M-0.10M-0.03M0.06M-0.07M-0.08M0.12M-0.10M0.06M0.04M-0.03M-0.06M-0.00M0.12M
Change in Cash
-19.94M26.67M-88.85M61.45M-26.21M-8.45M120.06M-35.58M-33.02M60.42M-19.41M-26.95M157.00M-8.86M-58.99M-34.58M-12.25M405.86M-57.47M-176.58M
Free Cash FlowFCF
-28.28M-7.05M-40.08M-29.31M-26.10M-33.64M85.03M-37.33M-34.66M-33.59M-33.85M-27.52M-46.86M-43.73M-63.20M-46.32M-44.91M-33.77M-59.99M-54.47M
Net Cash FlowNCF
-19.93M26.75M-88.77M61.59M-26.13M-8.54M120.09M-35.48M-32.98M60.37M-19.34M-26.87M156.88M-8.75M-59.05M-34.62M-12.22M405.92M-57.46M-176.71M